Vycor Medical (VYCO) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.58% |
| Dec 31, 2025 | 22.75% |
| Sep 30, 2025 | -61.56% |
| Jun 30, 2025 | 28.55% |
| Mar 31, 2025 | -96.43% |
| Dec 31, 2024 | -11.90% |
| Sep 30, 2024 | 2.32% |
| Jun 30, 2024 | 32.48% |
| Mar 31, 2024 | -23.53% |
| Dec 31, 2023 | -40.34% |
| Sep 30, 2023 | 6.93% |
| Jun 30, 2023 | 16.96% |
| Mar 31, 2023 | 16.05% |
| Dec 31, 2022 | 15.32% |
| Sep 30, 2022 | 44.04% |
| Jun 30, 2022 | 2.21% |
| Mar 31, 2022 | -15.10% |
| Dec 31, 2021 | 17.25% |
| Sep 30, 2021 | -25.46% |
| Jun 30, 2021 | 46.71% |
| Mar 31, 2021 | 50.86% |
| Dec 31, 2020 | 36.16% |
| Sep 30, 2020 | 14.99% |
| Jun 30, 2020 | 15.35% |
| Mar 31, 2020 | 69.79% |
| Sep 30, 2019 | 15.84% |
| Jun 30, 2019 | -17.31% |
| Mar 31, 2019 | -64.31% |
| Dec 31, 2018 | -15.69% |
| Sep 30, 2018 | 28.45% |
| Jun 30, 2018 | -34.28% |
| Mar 31, 2018 | -10.53% |
| Dec 31, 2017 | 8.27% |
| Sep 30, 2017 | -31.04% |
| Jun 30, 2017 | 31.15% |
| Mar 31, 2017 | 23.90% |
| Dec 31, 2016 | 42.25% |
| Sep 30, 2016 | 15.64% |
| Jun 30, 2016 | -14.95% |
| Mar 31, 2016 | -40.14% |
| Dec 31, 2015 | -40.22% |
| Sep 30, 2015 | -34.12% |